Literature DB >> 22170166

Sedation of children during measurement of CSF opening pressure: lack of standardisation in German children with pseudotumor cerebri.

D Tibussek1, F Distelmaier, S Kummer, R von Kries, E Mayatepek.   

Abstract

BACKGROUND: Diagnosis of pseudotumor cerebri (PTC) requires proper documentation of raised CSF opening-pressure. In childhood results may not be reliable due to insufficient sedation/analgesia or drug effects. We aimed to evaluate the current practice regarding pain and stress management in children undergoing lumbar puncture (LP) for pressure measurement.
METHODS: A one-year survey was conducted involving 368 German paediatric departments. All children with newly diagnosed PTC should be reported. Details analyzed here included: age, sex, CSF opening pressure and type of procedural sedation and analgesia (PSA) during LP.
RESULTS: 61 patients were analyzed, aged 6 months to 17 years. 29 patients (47%) did not receive any kind of PSA. In children receiving PSA the following regimens were used: Ketamine; Midazolam; Ketamine + Midazolam; Midazolam + Piritramide; Propofol; Profofol + Midazolam; general anaesthesia.
CONCLUSION: Pain and stress management in children undergoing LP for CSF opening pressure measurement is often insufficient. Pain, stress and the variability of PSA regimen may be confounders of pressure measurement. In order to prevent false diagnoses of PTC and to obtain comparable results at different centers, a general consensus on PSA in children undergoing LP for CSF opening pressure measurements is required. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 22170166     DOI: 10.1055/s-0031-1298020

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  1 in total

Review 1.  Infantile idiopathic intracranial hypertension: case report and review of the literature.

Authors:  Francesco Del Monte; Laura Bucchino; Antonia Versace; Irene Tardivo; Emanuele Castagno; Giovanni Pieri; Giulia Pilloni; Enrico Felici; Antonio Francesco Urbino
Journal:  Ital J Pediatr       Date:  2022-01-10       Impact factor: 2.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.